Cardiff Oncology | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Cardiff Oncology | 8-K: Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
Cardiff Oncology | 8-K: Current report
Cardiff Oncology | 8-K: Cardiff Oncology Reports Third Quarter 2023 Results and Provides Business Update
Cardiff Oncology | 8-K: Current report
Cardiff Oncology | 8-K: Cardiff Oncology Reports Second Quarter 2023 Results and Provides Business Update
Cardiff Oncology | 8-K: Current report
Cardiff Oncology | 8-K: Current report
Cardiff Oncology | 8-K: Current report
Cardiff Oncology | 8-K: Current report
Cardiff Oncology | 8-K: Cardiff Oncology Reports First-Quarter 2023 Results and Provides Business Update
Cardiff Oncology | DEFA14A: Others
Cardiff Oncology | DEF 14A: Definitive proxy statements
Cardiff Oncology | 8-K: Current report
Cardiff Oncology | 8-K: Cardiff Oncology Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update
Cardiff Oncology | 8-K: Current report
Cardiff Oncology | 8-K: Cardiff Oncology Reports Third Quarter 2022 Results and Provides Business Updates
Cardiff Oncology | 8-K: Current report
Cardiff Oncology | 8-K: Current report
Cardiff Oncology | 8-K: Current report
No Data